Resveratrol Promotes Remyelination in Cuprizone Model of Multiple Sclerosis: Biochemical and Histological Study

Molecular Neurobiology

Volumn 54, Issue 5, 2017, Pages 3219-3229

  Ghaiad, Heba R ^a   Nooh, Mohammed M ^a   El Sawalhi, Maha M ^a   Shaheen, Amira A ^a  

^a CAIRO UNIVERSITY   (Egypt)

Author keywords

Cuprizone; Demyelination; Multiple sclerosis; Olig1; Remyelination; Resveratrol

Indexed keywords

2',3' CYCLIC NUCLEOTIDE 3' PHOSPHODIESTERASE; ADENOSINE TRIPHOSPHATE; CUPRIZONE; CYTOCHROME C OXIDASE; GLUTATHIONE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN ALPHA; MYELIN; MYELIN BASIC PROTEIN; OLIGODENDROCYTE TRANSCRIPTION FACTOR 1; RESVERATROL; SUPEROXIDE DISMUTASE; THIOBARBITURIC ACID REACTIVE SUBSTANCE; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG; BIOLOGICAL MARKER; STILBENE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOCHEMICAL ANALYSIS; BODY EQUILIBRIUM; BRAIN LEVEL; BRAIN TISSUE; C57BL 6 MOUSE; CONTROLLED STUDY; CUPRIZONE-INDUCED DEMYELINATION; DRUG EFFICACY; ENZYME ACTIVITY; GENE EXPRESSION; HISTOPATHOLOGY; LIPID PEROXIDATION; MALE; MITOCHONDRIAL RESPIRATION; MOTOR COORDINATION; MOUSE; MULTIPLE SCLEROSIS; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; PROTEIN EXPRESSION; REMYELINIZATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; ROTAROD TEST; SIGNAL TRANSDUCTION; TREATMENT DURATION; ANIMAL; BRAIN; C57BL MOUSE; CHEMICALLY INDUCED; DISEASE MODEL; DRUG EFFECTS; INFLAMMATION; METABOLISM; MITOCHONDRION; MOTOR ACTIVITY; MYELIN SHEATH; PATHOLOGY;

ANIMALS; BIOMARKERS; BRAIN; CUPRIZONE; DISEASE MODELS, ANIMAL; INFLAMMATION; MALE; MICE, INBRED C57BL; MITOCHONDRIA; MOTOR ACTIVITY; MULTIPLE SCLEROSIS; MYELIN SHEATH; OXIDATIVE STRESS; REMYELINATION; STILBENES;

EID: 84962808791     PISSN: 08937648     EISSN: 15591182     Source Type: Journal    
DOI: 10.1007/s12035-016-9891-5     Document Type: Article

References (57)

1. Münzel EJ, Williams A (2013) Promoting remyelination in multiple sclerosis-recent advances. Drugs 73:2017–2029. doi:10.1007/s40265-013-0146-8
2. Arnett HA, Fancy SPJ, Alberta JA et al (2004) bHLH transcription factor Olig1 is required to repair demyelinated lesions in the CNS. Science 306:2111–2115. doi:10.1126/science.1103709
3. Rodriguez M, Scheithauer BW, Forbes G, Kelly PJ (1993) Oligodendrocyte injury is an early event in lesions of multiple sclerosis. Mayo Clin Proc 68:627–636. doi:10.1016/S0025-6196(12)60597-7
4. Rodriguez M (2007) Effectors of demyelination and remyelination in the CNS: implications for multiple sclerosis. Brain Pathol 17:219–229. doi:10.1111/j.1750-3639.2007.00065.x
5. Chang A, Tourtellotte WW, Rudick R, Trapp BD (2002) Premyelinating oligodendrocytes in chronic lesions of multiple sclerosis. N Engl J Med 346:165–173. doi:10.1056/NEJMoa010994
6. Keirstead HS, Blakemore WF (1997) Identification of post-mitotic oligodendrocytes incapable of remyelination within the demyelinated adult spinal cord. J Neuropathol Exp Neurol 56:1191–201
7. Franklin RJM, Ffrench-Constant C (2008) Remyelination in the CNS: from biology to therapy. Nat Rev Neurosci 9:839–855. doi:10.1038/nrn2480
8. Chang A, Nishiyama A, Peterson J et al (2000) NG2-positive oligodendrocyte progenitor cells in adult human brain and multiple sclerosis lesions. J Neurosci 20:6404–6412
9. Meijer DH, Kane MF, Mehta S et al (2012) Separated at birth? The functional and molecular divergence of OLIG1 and OLIG2. Nat Rev Neurosci 13:819–31. doi:10.1038/nrn3386
10. Zendedel A, Beyer C, Kipp M (2013) Cuprizone-induced demyelination as a tool to study remyelination and axonal protection. J Mol Neurosci 51:567–572. doi:10.1007/s12031-013-0026-4
11. Ludwin SK (1978) Central nervous system demyelination and remyelination in the mouse: an ultrastructural study of cuprizone toxicity. Lab Invest 39:597–612
12. Praet J, Guglielmetti C, Berneman Z et al (2014) Cellular and molecular neuropathology of the cuprizone mouse model: clinical relevance for multiple sclerosis. Neurosci Biobehav Rev 47:485–505. doi:10.1016/j.neubiorev.2014.10.004
13. Venturini G (1973) Enzymic activities and sodium, potassium and copper concentrations in mouse brain and liver after cuprizone treatment in vivo. J Neurochem 21:1147–1151. doi:10.1111/j.1471-4159.1973.tb07569.x
14. Groebe A, Clarner T, Baumgartner W et al (2009) Cuprizone treatment induces distinct demyelination, astrocytosis, and microglia cell invasion or proliferation in the mouse cerebellum. Cerebellum 8:163–174. doi:10.1007/s12311-009-0099-3
15. Hiremath MMM, Saito Y, Knapp GWW et al (1998) Microglial/macrophage accumulation during cuprizone-induced demyelination in C57Bl/6 mice. J Neuroimmunol 92:38–49. doi:10.1016/S0165-5728(98)00168-4
16. Rice CM, Sun M, Kemp K et al (2012) Mitochondrial sirtuins—a new therapeutic target for repair and protection in multiple sclerosis. Eur J Neurosci 35:1887–1893. doi:10.1111/j.1460-9568.2012.08150.x
17. Campbell GR, Ziabreva I, Reeve AK et al (2011) Mitochondrial DNA deletions and neurodegeneration in multiple sclerosis. Ann Neurol 69:481–492. doi:10.1002/ana.22109
18. Carlson NG, Rose JW (2006) Antioxidants in multiple sclerosis: do they have a role in therapy? CNS Drugs 20:433–441. doi:10.2165/00023210-200620060-00001
19. Cuzzola F, Ciurleo R, Giacoppo S et al (2011) Role of resveratrol and its analogues in the treatment of neurodegenerative diseases: focus on recent discoveries. CNS Neurol Disord Drug Targets 10:849–62
20. Shindler K, Ventura E, Dutt M (2010) Oral resveratrol reduces neuronal damage in a model of multiple sclerosis. J Neurol 30:328–339. doi:10.1097/WNO.0b013e3181f7f833.Oral
21. Fonseca-Kelly Z, Nassrallah M, Uribe J, et al (2012) Resveratrol neuroprotection in a chronic mouse model of multiple sclerosis. Front Neurol 1–9. doi:10.3389/fneur.2012.00084
22. Bando Y, Ito S, Nagai Y et al (2006) Implications of protease M/neurosin in myelination during experimental demyelination and remyelination. Neurosci Lett 405:175–180. doi:10.1016/j.neulet.2006.06.030
23. Deacon RMJ (2013) Measuring motor coordination in mice. J Vis Exp e2609. doi:10.3791/2609
24. Yoshikawa K, Palumbo S, Toscano CD, Bosetti F (2011) Inhibition of 5-lipoxygenase activity in mice during cuprizone-induced demyelination attenuates neuroinflammation, motor dysfunction and axonal damage. Prostaglandins Leukot Essent Fatty Acids 85:43–52. doi:10.1016/j.plefa.2011.04.022
25. Buege JA, Aust SD (1974) Microsomal lipid peroxidation. In: Methods Enzym. pp 302–310
26. Tietze F (1969) Enzymic method for quantitative determination of nanogram amounts of total and oxidized glutathione: applications to mammalian blood and other tissues. Anal Biochem 27:502–522. doi:10.1016/0003-2697(69)90064-5
27. Navarro A, Boveris A (2004) Rat brain and liver mitochondria develop oxidative stress and lose enzymatic activities on aging. Am J Physiol Regul Integr Comp Physiol 287:R1244–R1249. doi:10.1152/ajpregu.00226.2004
28. Marklund S, Marklund G (1974) Involvement of the superoxide anion radical in the autoxidation of pyrogallol and a convenient assay for superoxide dismutase. Eur J Biochem 47:469–474. doi:10.1111/j.1432-1033.1974.tb03714.x
29. Paradies G, Petrosillo G, Pistolese M, Ruggiero FM (2000) The effect of reactive oxygen species generated from the mitochondrial electron transport chain on the cytochrome c oxidase activity and on the cardiolipin content in bovine heart submitochondrial particles. FEBS Lett 466:323–326. doi:10.1016/S0014-5793(00)01082-6
30. Lowry OH, Rosebrough NJ, Farr L, Randall RJ (1951) Protein measurement with the folin phenol reagent. J Biol Chem
31. Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(−Delta Delta C(T)) method. Methods 25:402–8. doi:10.1006/meth.2001.1262
32. Gudi V, Gingele S, Skripuletz T, Stangel M (2014) Glial response during cuprizone-induced de- and remyelination in the CNS: lessons learned. Front Cell Neurosci 8:73. doi:10.3389/fncel.2014.00073
33. Bando Y, Takakusaki K, Ito S et al (2008) Differential changes in axonal conduction following CNS demyelination in two mouse models. Eur J Neurosci 28:1731–1742. doi:10.1111/j.1460-9568.2008.06474.x
34. Fulton D, Paez PM, Campagnoni AT (2010) The multiple roles of myelin protein genes during the development of the oligodendrocyte. ASN Neuro 2:e00027. doi:10.1042/AN20090051
35. Nave K-A (2010) Myelination and the trophic support of long axons. Nat Rev Neurosci 11:275–283. doi:10.1038/nrn2797
36. Lindner M, Heine S, Haastert K et al (2008) Sequential myelin protein expression during remyelination reveals fast and efficient repair after central nervous system demyelination. Neuropathol Appl Neurobiol 34:105–114. doi:10.1111/j.1365-2990.2007.00879.x
37. Baxi EG, DeBruin J, Tosi DM et al (2015) Transfer of myelin-reactive Th17 cells impairs endogenous remyelination in the central nervous system of cuprizone-fed mice. J Neurosci 35:8626–8639. doi:10.1523/JNEUROSCI.3817-14.2015
38. Roher AE, Weiss N, Kokjohn TA et al (2002) Increased Aβ peptides and reduced cholesterol and myelin proteins characterize white matter degeneration in Alzheimer’ s disease. Biochemistry 41:11080–11090. doi:10.1021/bi026173d
39. Frid K, Einstein O, Friedman-Levi Y et al (2015) Aggregation of MBP in chronic demyelination. Ann Clin Transl Neurol 2:711–721. doi:10.1002/acn3.207
40. Gudi V, Moharregh-Khiabani D, Skripuletz T et al (2009) Regional differences between grey and white matter in cuprizone induced demyelination. Brain Res 1283:127–138. doi:10.1016/j.brainres.2009.06.005
41. Targett MP, Sussman J, Scolding N et al (1996) Failure to achieve remyelination of demyelinated rat axons following transplantation of glial cells obtained from the adult human brain. Neuropathol Appl Neurobiol 22:199–206
42. Boyd A, Zhang H, Williams A (2013) Insufficient OPC migration into demyelinated lesions is a cause of poor remyelination in MS and mouse models. Acta Neuropathol 125:841–859. doi:10.1007/s00401-013-1112-y
43. Dai J, Bercury KK, Ahrendsen JT, Macklin WB (2015) Olig1 function is required for oligodendrocyte differentiation in the mouse brain. J Neurosci 35:4386–4402. doi:10.1523/JNEUROSCI.4962-14.2015
44. El Waly B, Macchi M, Cayre M, Durbec P (2014) Oligodendrogenesis in the normal and pathological central nervous system. Front Neurosci 8:1–22. doi:10.3389/fnins.2014.00145
45. Ziabreva I, Campbell G, Rist J et al (2010) Injury and differentiation following inhibition of mitochondrial respiratory chain complex IV in rat oligodendrocytes. Glia 58:1827–1837. doi:10.1002/glia.21052
46. Nguyen NTQ, Ooi L, Piller SC, Münch G (2013) Proenergetic effects of resveratrol in the murine neuronal cell line neuro2a. Mol Nutr Food Res 57:1901–1907. doi:10.1002/mnfr.201300145
47. Csiszar A, Labinskyy N, Pinto JT et al (2009) Resveratrol induces mitochondrial biogenesis in endothelial cells. Am J Physiol Hear Circ Physiol 297:H13–H20. doi:10.1152/ajpheart.00368.2009
48. Price NL, Gomes AP, Ling AJY et al (2012) SIRT1 is required for AMPK activation and the beneficial effects of resveratrol on mitochondrial function. Cell Metab 15:675–690. doi:10.1016/j.cmet.2012.04.003
49. Mc Guire C, Prinz M, Beyaert R, van Loo G (2013) Nuclear factor kappa B (NF-KappaB) in multiple sclerosis pathology. Trends Mol Med 19:604–613. doi:10.1016/j.molmed.2013.08.001
50. Vakilzadeh G, Khodagholi F, Ghadiri T et al (2015) The effect of melatonin on behavioral, molecular, and histopathological changes in cuprizone model of demyelination. Mol Neurobiol. doi:10.1007/s12035-015-9404-y
51. Camandola S, Mattson MP (2007) NF-kappa B as a therapeutic target in neurodegenerative diseases. Expert Opin Ther Targets 11:123–132. doi:10.1517/14728222.11.2.123
52. Raasch J, Zeller N, Van Loo G et al (2011) IκB kinase 2 determines oligodendrocyte loss by non-cell-autonomous activation of NF-KappaB in the central nervous system. Brain 134:1184–1198. doi:10.1093/brain/awq359
53. Voß EV, Škuljec J, Gudi V et al (2012) Characterisation of microglia during de- and remyelination: can they create a repair promoting environment? Neurobiol Dis 45:519–528. doi:10.1016/j.nbd.2011.09.008
54. Singh NP, Hegde VL, Hofseth LJ et al (2007) Resveratrol (trans-3,5,4′-trihydroxystilbene) ameliorates experimental allergic encephalomyelitis, primarily via induction of apoptosis in T cells involving activation of aryl hydrocarbon receptor and estrogen receptor. Mol Pharmacol 72:1508–1521. doi:10.1124/mol.107.038984.compounds
55. Skripuletz T, Miller E, Moharregh-Khiabani D et al (2010) Beneficial effects of minocycline on cuprizone induced cortical demyelination. Neurochem Res 35:1422–1433. doi:10.1007/s11064-010-0202-7
56. Hibbits N, Pannu R, Wu TJ, Armstrong RC (2009) Cuprizone demyelination of the corpus callosum in mice correlates with altered social interaction and impaired bilateral sensorimotor coordination. ASN Neuro 1:153–164. doi:10.1042/AN20090032
57. Bagriyanik HA, Ersoy N, Cetinkaya C et al (2014) The effects of resveratrol on chronic constriction injury of sciatic nerve in rats. Neurosci Lett 561:123–127. doi:10.1016/j.neulet.2013.12.056